What does Ningxia Zhongke Biotechnology Co., Ltd. do?

Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) operates in the Chemicals - Specialty industry within the Basic Materials sector. Full company description, peers, and segment breakdown are on the page above.

What is 600165.SS's market cap?

Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) has a market capitalization of approximately $5.11 billion, as of August 28, 2026, based on the most recent share price and shares outstanding.

Does 600165.SS pay a dividend?

Yes — Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 600165.SS profitable?

Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

600165.SS

Ningxia Zhongke Biotechnology Co., Ltd.

SHH·Chemicals, Specialty · Basic Materials

¥3.16¥0.06−1.86%

Market cap¥5.11B·Aug 28 7:00 AM UTC

Price Chart

¥3.16−¥0.06 (−1.86%)today

−68.62%CAGR −20.71%

Select date range

FromTo

May 29, 1998Aug 28, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

600165.SS does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 16

Last Report DateJun 30

Reported vs Estimate−¥0.16

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥468.31M

Net Income−¥90.62M

Net Margin−19.3%

Operating Cash Flow−¥452.40M

Capital Expenditures¥291.27M

Free Cash Flow−¥743.67M

Return on Equity−7.9%

Return on Invested Capital−3.0%

Net Debt¥588.78M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 600165.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 600165.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 600165.SS and 80,000+ other tickers.

About Ningxia Zhongke Biotechnology Co., Ltd.

Ningxia Zhongke Biotechnology Co., Ltd., established in 1958 and headquartered in Yinchuan, China, operates in the chemical sector. The company specializes in the production of both chemical raw materials and a diverse range of chemical products. Its manufacturing activities specifically encompass coal-based activated carbon, various lauric acid compounds, and biologically-derived chemical fibers.

CEO: Jie Fu
Sector: Basic Materials
Industry: Chemicals - Specialty
Exchange: SHH
Employees: 904
Website: www.ningkeshengwu.com

Peers

Peers Tab

603028.SS

Jiangsu Safety Group Co.,Ltd.

Cap

¥2.0B

603616.SS

Beijing Hanjian Heshan Pipeline Co.,Ltd

Cap

¥2.1B

300234.SZ

Zhejiang Kaier New Materials Co.,Ltd.

Cap

¥5.1B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 600165.SS

What does Ningxia Zhongke Biotechnology Co., Ltd. do?: Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) operates in the Chemicals - Specialty industry within the Basic Materials sector. Full company description, peers, and segment breakdown are on the page above.
What is 600165.SS's market cap?: Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) has a market capitalization of approximately $5.11 billion, as of August 28, 2026, based on the most recent share price and shares outstanding.
Does 600165.SS pay a dividend?: Yes — Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 600165.SS profitable?: Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.